Dexamethasone, but Not Vitamin D or A, Dampens the Inflammatory Neutrophil Response to Protect At-risk COVID-19 Patients

Dexamethasone (DEX) was the first drug shown to save lives of critically ill coronavirus disease 2019 (COVID-19) patients suffering from respiratory distress. A hyperactivated state of neutrophils was found in COVID-19 patients compared to non-COVID pneumonia cases. Given the beneficial effects of D...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafkamp, Florianne M.J., Mol, Sanne, Waqué, Iris, De Jong, Esther C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433192/
https://www.ncbi.nlm.nih.gov/pubmed/36081524
http://dx.doi.org/10.4110/in.2022.22.e36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433192/
https://www.ncbi.nlm.nih.gov/pubmed/36081524
http://dx.doi.org/10.4110/in.2022.22.e36

Ejemplares similares